170 related articles for article (PubMed ID: 3258793)
41. Studies on cytotoxicity generated in human mixed lymphocyte culture. IV. Interleukin 2 alone or from mixed lymphocyte culture yields natural killer-like cytotoxic cells distinct from allospecific cytotoxic T lymphocytes.
Shau H; Gray JD; Golub SH
Cancer Immunol Immunother; 1988; 27(3):255-60. PubMed ID: 2972366
[TBL] [Abstract][Full Text] [Related]
42. IL-4 inhibits IL-2-mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures.
Spits H; Yssel H; Paliard X; Kastelein R; Figdor C; de Vries JE
J Immunol; 1988 Jul; 141(1):29-36. PubMed ID: 2454260
[TBL] [Abstract][Full Text] [Related]
43. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2.
Suzuki R; Suzuki S; Ebina N; Kumagai K
J Immunol; 1985 Apr; 134(4):2139-48. PubMed ID: 2579129
[TBL] [Abstract][Full Text] [Related]
44. Target cell-induced inactivation of cytolytic lymphocytes. Role and regulation of CD45 and calyculin A-inhibited phosphatase in response to interleukin-2.
Bajpai A; Brahmi Z
J Biol Chem; 1994 Jul; 269(29):18864-9. PubMed ID: 8034641
[TBL] [Abstract][Full Text] [Related]
45. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
Vujanovic NL; Herberman RB; Olszowy MW; Cramer DV; Salup RR; Reynolds CW; Hiserodt JC
Cancer Res; 1988 Feb; 48(4):884-90. PubMed ID: 3257412
[TBL] [Abstract][Full Text] [Related]
46. Lack of reconstitution of nude mice alloreactivity by purified interleukin 2 and induction of non-H-2-specific effector cells by crude supernatants.
Harel-Bellan A; Quillet A; Marchiol C; Gerard JP; Fradelizi D
Cell Immunol; 1987 Apr; 105(2):251-61. PubMed ID: 3494525
[TBL] [Abstract][Full Text] [Related]
47. Allogeneic cell-mediated immunotherapy for eradication of minimal residual disease: comparison of T-cell and IL-2 activated killer (LAK) cell-mediated adoptive immunotherapy in murine models.
Vourka-Karussis U; Ackerstein A; Pugatsch T; Slavin S
Exp Hematol; 1999 Mar; 27(3):461-9. PubMed ID: 10089908
[TBL] [Abstract][Full Text] [Related]
48. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.
Rosenstein M; Yron I; Kaufmann Y; Rosenberg SA
Cancer Res; 1984 May; 44(5):1946-53. PubMed ID: 6608989
[TBL] [Abstract][Full Text] [Related]
49. Inhibitory effects of alloimmune T cells on the generation of cytolytic responses of lymphokine-activated killer cells.
Sugarbaker PH; Matthews W; Steller EP; Eggermont AM
J Biol Response Mod; 1987 Aug; 6(4):430-45. PubMed ID: 3498012
[TBL] [Abstract][Full Text] [Related]
50. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
Grimm EA; Mazumder A; Zhang HZ; Rosenberg SA
J Exp Med; 1982 Jun; 155(6):1823-41. PubMed ID: 6176669
[TBL] [Abstract][Full Text] [Related]
51. Murine lymphokine-activated killer (LAK) cells: phenotypic characterization of the precursor and effector cells.
Yang JC; Mulé JJ; Rosenberg SA
J Immunol; 1986 Jul; 137(2):715-22. PubMed ID: 2873187
[TBL] [Abstract][Full Text] [Related]
52. Target cell-directed inactivation and IL-2-dependent reactivation of LAK cells.
Xiao J; Brahmi Z
Cell Immunol; 1989 Sep; 122(2):295-306. PubMed ID: 2788512
[TBL] [Abstract][Full Text] [Related]
53. Lymphokine-activated killer cells are generated before classical cytotoxic T lymphocytes after bone marrow transplantation in mice.
Merluzzi VJ; Savage DM; Smith MD; Last-Barney K; Mertelsmann R; Moore MA; Welte K
J Immunol; 1985 Sep; 135(3):1702-6. PubMed ID: 3894518
[TBL] [Abstract][Full Text] [Related]
54. Activity inhibition of cytolytic lymphocytes by omeprazole.
Scaringi L; Cornacchione P; Fettucciari K; Rosati E; Rossi R; Marconi P; Capodicasa E
Scand J Immunol; 1996 Sep; 44(3):204-14. PubMed ID: 8795713
[TBL] [Abstract][Full Text] [Related]
55. Immunotoxicity of N,N-diethylaniline in mice: effect on natural killer activity, cytotoxic T lymphocyte activity, lymphocyte proliferation response and cellular components of the spleen.
Li Q; Hirata Y; Piao S; Minami M
Toxicology; 2000 Sep; 150(1-3):179-89. PubMed ID: 10996674
[TBL] [Abstract][Full Text] [Related]
56. Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells.
Maghazachi AA; Vujanovic NL; Herberman RB; Hiserodt JC
J Immunol; 1988 Apr; 140(8):2846-52. PubMed ID: 3258622
[TBL] [Abstract][Full Text] [Related]
57. Modulation of cell-mediated immunity by lithium chloride.
Kubera M; Bubak-Satora M; Holan V; Krol W; Basta-Kaim A; Roman A; Skowron-Cendrzak A; Shani J
Z Naturforsch C J Biosci; 1994; 49(9-10):679-83. PubMed ID: 7945679
[TBL] [Abstract][Full Text] [Related]
58. Comparison of murine lymphokine-activated killer cells, natural killer cells, and cytotoxic T lymphocytes.
Merluzzi VJ
Cell Immunol; 1985 Oct; 95(1):95-104. PubMed ID: 3875426
[TBL] [Abstract][Full Text] [Related]
59. Lymphokine-activated killer cells in mouse bone marrow chimaeras. The relationship to natural killer cells and to alloreactive cytotoxic T cells.
Sihvola M
Scand J Immunol; 1985 Nov; 22(5):479-88. PubMed ID: 2867599
[TBL] [Abstract][Full Text] [Related]
60. In vitro effects of an antitumor antibiotic, ascofuranone, on the murine immune system.
Magae J; Suzuki S; Nagai K; Yamasaki M; Ando K; Tamura G
Cancer Res; 1986 Mar; 46(3):1073-8. PubMed ID: 3080231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
